Hypothalamic serotonin-1A receptor binding measured by PET predicts the plasma level of dehydroepiandrosterone sulfate in healthy women

Neuroscience Letters

Volumn 476, Issue 3, 2010, Pages 161-165

  Moser, Ulrike ^a   Wadsak, Wolfgang ^a   Spindelegger, Christoph ^a   Mitterhauser, Markus ^a   Mien, Leonhard Key ^a   Bieglmayer, Christian ^a   Kletter, Kurt ^a   Kasper, Siegfried ^a   Lanzenberger, Rupert ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

5 HT1A receptor; DHEAS; HPA axis; Hypothalamus; PET

Indexed keywords

CARBON 11; CARBONYL DERIVATIVE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; HYDROCORTISONE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; PRASTERONE SULFATE; RADIOLIGAND; SEROTONIN 1A RECEPTOR;

AMYGDALOID NUCLEUS; ANDROGEN BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; BRAIN REGION; CEREBELLUM; CINGULATE GYRUS; CONTROLLED STUDY; CORTICOTROPIN RELEASE; DORSAL RAPHE NUCLEUS; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IN VIVO STUDY; INSULA; MALE; NEUROMODULATION; NORMAL HUMAN; ORBITAL CORTEX; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; RECEPTOR BINDING; RETROSPLENIAL CORTEX; SEROTONINERGIC SYSTEM;

ADULT; CARBON RADIOISOTOPES; DEHYDROEPIANDROSTERONE SULFATE; FEMALE; HUMANS; HYDROCORTISONE; HYPOTHALAMUS; PIPERAZINES; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PYRIDINES; RADIOPHARMACEUTICALS; RECEPTOR, SEROTONIN, 5-HT1A; YOUNG ADULT;

EID: 77952884054     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.04.020     Document Type: Article

References (30)

1. Alesci S., Bornstein S.R. Intraadrenal mechanisms of DHEA regulation: a hypothesis for adrenopause. Exp. Clin. Endocrinol. Diabetes 2001, 109:75-82.
2. Allolio B., Arlt W. DHEA treatment: myth or reality?. Trends Endocrinol. Metab. 2002, 13:288-294.
3. Arvat E., Di Vito L., Lanfranco F., Maccario M., Baffoni C., Rossetto R., Aimaretti G., Camanni F., Ghigo E. Stimulatory effect of adrenocorticotropin on cortisol, aldosterone, and dehydroepiandrosterone secretion in normal humans: dose-response study. J. Clin. Endocrinol. Metab. 2000, 85:3141-3146.
4. Bremner J.D, Bronen R.A., De Erasquin G., Vermetten E., Staib L.H., Ng C.K., Soufer R., Charney D.S., Innis R.B. Development and reliability of a method for using magnetic resonance imaging for the definition of regions of interest for positron emission tomography. Clin. Positron Imaging 1998, 1:145-159.
5. Bush V.L., Middlemiss D.N., Marsden C.A., Fone K.C. Implantation of a slow release corticosterone pellet induces long-term alterations in serotonergic neurochemistry in the rat brain. J. Neuroendocrinol. 2003, 15:607-613.
6. Carlson P.J., Bain E., Tinsley R., Nugent A., Carson R., Luckenbaugh D., Kling M., Gold P., Remaley A., Drevets W.C. Relationship between serotonin-1A binding and HPA axis in subjects with major depression and healthy controls. NeuroImage 2008, 41:T146.
7. Christensen M.V., Kessing L.V. The hypothalamo-pituitary-adrenal axis in major affective disorder: a review. Nord. J. Psychiatr. 2001, 55:359-363.
8. Cleare A.J., O'Keane V., Miell J.P. Levels of DHEA and DHEAS and responses to CRH stimulation and hydrocortisone treatment in chronic fatigue syndrome. Psychoneuroendocrinology 2004, 29:724-732.
9. Compaan J.C., Groenink L., van der Gugten J., Maes R.A., Olivier B. 5-HT1A receptor agonist flesinoxan enhances Fos immunoreactivity in rat central amygdala, bed nucleus of the stria terminalis and hypothalamus. Eur. J. Neurosci. 1996, 8:2340-2347.
10. de Kloet E.R., Joels M., Holsboer F. Stress and the brain: from adaptation to disease. Nat. Rev. Neurosci. 2005, 6:463-475.
11. Di Sciullo A., Bluet-Pajot M.T., Mounier F., Oliver C., Schmidt B., Kordon C. Changes in anterior pituitary hormone levels after serotonin 1A receptor stimulation. Endocrinology 1990, 127:567-572.
12. Drevets W.C., Thase M.E., Moses-Kolko E.L., Price J., Frank E., Kupfer D.J., Mathis C. Serotonin-1A receptor imaging in recurrent depression: replication and literature review. Nucl. Med. Biol. 2007, 34:865-877.
13. Hensler J.G., Advani T., Monteggia L.M. Regulation of serotonin-1A receptor function in inducible brain-derived neurotrophic factor knockout mice after administration of corticosterone. Biol. Psychiatr. 2007, 62:521-529.
14. Hucklebridge F., Hussain T., Evans P., Clow A. The diurnal patterns of the adrenal steroids cortisol and dehydroepiandrosterone (DHEA) in relation to awakening. Psychoneuroendocrinology 2005, 30:51-57.
15. Ibanez L., Potau N., Marcos M.V., de Zegher F. Corticotropin-releasing hormone as adrenal androgen secretagogue. Pediatr. Res. 1999, 46:351-353.
16. Ibanez L., Potau N., Marcos M.V., de Zegher F. Corticotropin-releasing hormone: a potent androgen secretagogue in girls with hyperandrogenism after precocious pubarche. J. Clin. Endocrinol. Metab. 1999, 84:4602-4606.
17. Kasper S., Vieira A., Schmidt R., Richter P. Multiple hormone responses to stimulation with dl-fenfluramine in patients with major depression before and after antidepressive treatment. Pharmacopsychiatry 1990, 23:76-84.
18. Lanzenberger R.R., Mitterhauser M., Spindelegger C., Wadsak W., Klein N., Mien L.K., Holik A., Attarbaschi T., Mossaheb N., Sacher J., Geiss-Granadia T., Kletter K., Kasper S., Tauscher J. Reduced serotonin-1A receptor binding in social anxiety disorder. Biol. Psychiatr. 2007, 61:1081-1089.
19. Lopez J.F., Chalmers D.T., Little K.Y., Watson S.J., Bennett A.E. Research Award. Regulation of serotonin1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression. Biol. Psychiatr. 1998, 43:547-573.
20. Mikkelsen J.D., Hay-Schmidt A., Kiss A. Serotonergic stimulation of the rat hypothalamo-pituitary-adrenal axis: interaction between 5-HT1A and 5-HT2A receptors. Ann. N. Y. Acad. Sci. 2004, 1018:65-70.
21. Montgomery A.J., Bench C.J., Young A.H., Hammers A., Gunn R.N., Bhagwagar Z., Grasby P.M. PET measurement of the influence of corticosteroids on serotonin-1A receptor number. Biol. Psychiatr. 2001, 50:668-676.
22. Nieschlag E., Loriaux D.L., Ruder H.J., Zucker I.R., Kirschner M.A., Lipsett M.B. The secretion of dehydroepiandrosterone and dehydroepiandrosterone sulphate in man. J. Endocrinol. 1973, 57:123-134.
23. Odell W.D., Parker L.N. Control of adrenal androgen production. Endocr. Res. 1984, 10:617-630.
24. Pan L., Gilbert F. Activation of 5-HT1A receptor subtype in the paraventricular nuclei of the hypothalamus induces CRH and ACTH release in the rat. Neuroendocrinology 1992, 56:797-802.
25. Parsey R.V., Oquendo M.A., Ogden R.T., Olvet D.M., Simpson N., Huang Y.Y., Van Heertum R.L., Arango V., Mann J.J. Altered serotonin 1A binding in major depression: a [carbonyl-C-11]WAY100635 positron emission tomography study. Biol. Psychiatr. 2006, 59:106-113.
26. Rickels K. Buspirone in clinical practice. J. Clin. Psychiatr. 1990, 51(Suppl.):51-54.
27. Rickels K., Amsterdam J., Clary C., Hassman J., London J., Puzzuoli G., Schweizer E. Buspirone in depressed outpatients: a controlled study. Psychopharmacol. Bull. 1990, 26:163-167.
28. Smith R., Mesiano S., Chan E.C., Brown S., Jaffe R.B. Corticotropin-releasing hormone directly and preferentially stimulates dehydroepiandrosterone sulfate secretion by human fetal adrenal cortical cells. J. Clin. Endocrinol. Metab. 1998, 83:2916-2920.
29. Spindelegger C., Lanzenberger R., Wadsak W., Mien L.K., Stein P., Mitterhauser M., Moser U., Holik A., Pezawas L., Kletter K., Kasper S. Influence of escitalopram treatment on 5-HT 1A receptor binding in limbic regions in patients with anxiety disorders. Mol. Psychiatr. 2009, 14:1040-1050.
30. Stein P., Savli M., Wadsak W., Mitterhauser M., Fink M., Spindelegger C., Mien L.K., Moser U., Dudczak R., Kletter K., Kasper S., Lanzenberger R. The serotonin-1A receptor distribution in healthy men and women measured by PET and [carbonyl-11C]WAY-100635. Eur. J. Nucl. Med. Mol. Imaging 2008, 35:2159-2168.